Mucosal immunology, eosinophilic esophagitis, and other intestinal inflammatory diseases - 11/08/11
![](/templates/common/images/mail.png)
![](/templates/common/images/entites/lowast.gif)
Abstract |
The gastrointestinal mucosa constitutes the largest host-environment interface of the body. It uses both innate and adaptive immune mechanisms to provide protection from the diverse onslaught of foods, microbes, and other ingested products. The innate immune system is genetically encoded and evolutionarily ancient, possesses no memory, and lacks diversity. In contrast, the adaptive immune system is quite diverse, develops memory, and undergoes expansion after stimulation. The gastrointestinal mucosa is charged with the difficult task of mounting protective responses against invading microorganisms while simultaneously maintaining an overall state of nonresponsiveness or tolerance to innocuous substances, such as commensal bacteria and food antigens. Perturbation or malfunction of these complex protective mechanisms results in diseases, such as inflammatory bowel diseases, celiac disease, or eosinophilic gastrointestinal diseases.
Le texte complet de cet article est disponible en PDF.Key words : Mucosal immunity, eosinophilic esophagitis, eosinophilic gastrointestinal diseases
Abbreviations used : DC, EGID, EoE, FAE, Foxp3, GALT, IBD, IEL, LP, M, NOD, PP, TCR, Treg
Plan
Disclosure of potential conflict of interest: D. Atkins has received research support from the National Institutes of Health Consortium of Food Allergy Research. G. T. Furuta is a consultant for Meritage Pharma, has received research support from the American Gastroenerological Association and the National Institutes of Health, and has provided expert witness testimony on the subject of eosinophilic esophagitis. |
Vol 125 - N° 2S2
P. S255-S261 - février 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?